Navigation Links
BYU engineers conceive disc replacement to treat chronic low back pain
Date:6/12/2012

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement.

While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

A new biomedical device to surgically treat chronic back pain an artificial spinal disc that duplicates the natural motion of the spine has been licensed from Brigham Young University to a Utah-based company.

The artificial disc was conceived by engineering professors Anton Bowden and Larry Howell and BYU alum Peter Halverson. It will be developed to market by Crocker Spinal Technologies, a company founded by BYU President's Leadership Council member Gary Crocker and headed by BYU MBA graduate David Hawkes.

The BYU researchers report on the mechanism's ability to facilitate natural spine movement in a study published in a forthcoming issue of the International Journal of Spine Surgery.

"Low back pain has been described as the most severe pain you can experience that won't kill you," said Bowden, a BYU biomechanics and spine expert. "This device has the potential to alleviate that pain and restore the natural motion of the spine something current procedures can't replicate."

Currently, the most common surgical treatment for chronic low back pain is spinal fusion surgery. Fusion replaces the degenerative disc with bone in order to fuse the adjacent segments to prevent motion-generated pain.

Unfortunately, patient satisfaction with fusion surgery is less than 50 percent.

The solution researched by the BYU team, and now being developed by Crocker Spinal Technologies, consists of a compliant mechanism that facilitates natural spine movement and is aimed at restoring the function of a healthy spinal disc.

Compliant mechanisms are jointless, elastic structures that use flexibility to create movement. Examples include tweezers, fingernail clippers or a bow-and-arrow. Howell is a leading expert in compliant mechanism research.

"To mimic the response of the spine is very difficult because of the constrained space and the sophistication of the spine and its parts," Howell said. "A compliant mechanism is more human-like, more natural, and the one we've created behaves like a healthy disc."

Under Howell's and Bowden's tutelage, BYU student-engineers built prototypes, machine tested the disc and then tested the device in cadaveric spines. The test results show the artificial replacement disc behaves similarly to a healthy human disc.

"Putting it in a cadaver and having it do what we engineered it do was really rewarding," Howell said. "It has a lot of promise for eventually making a difference in a lot of people's lives."

Halverson, who was lead author on the International Journal of Spine Surgery study, has since earned his Ph.D. from BYU and taken a position at Crocker Spinal Technologies, which will likely begin international sales distribution as early as next year.

"Fusion, which is the current standard of care for back pain, leaves a lot to be desired," said Hawkes, president of Crocker Spinal Technologies. "Disc replacement is an emerging alternative to fusion that has the potential to make a significant difference in the lives of millions.

"BYU's innovation is a radical step forward in the advancement of disc replacement technology. It is exciting to be a part of this effort and a delight to work with such talented, wonderful people," he said.


'/>"/>
Contact: Todd Hollingshead
toddh@byu.edu
801-422-8373
Brigham Young University
Source:Eurekalert

Related biology news :

1. Civil engineers find savings where the rubber meets the road
2. Engineers use droplet microfluidics to create glucose-sensing microbeads
3. When cells hit the wall: UCLA engineers put the squeeze on cells to diagnose disease
4. Chemical engineers at UMass Amherst find high-yield method of making xylene from biomass
5. Queens is UK leader for female scientists and engineers
6. Heart-powered pacemaker could one day eliminate battery-replacement surgery
7. Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
8. Manipulating chromatin loops to regulate genes may offer future treatments for blood diseases
9. The first pilot wastewater treatment plant with integrated wood production opened in Mongolia
10. New treatment for irritability in autism
11. The effect of treatment with antibiotics and vaccination against Q fever in sheep
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology: